Posted June 9, 2022 at 1:38 pm
Smaller font Reduce the font size of the article
-ONE Larger font Increase the font size of the article A + A neonatal screening program at Cadham Provincial Laboratory is expanding its services to include spinal muscular atrophy (SMA). According to the province, SMA is one of the most common causes of fatal genetic disorders in children, affecting about one in 18,000 babies.
Read more: Researchers say they have found the reason why babies die of SIDS
“Being able to extend the neonatal screening program means faster, more accurate information and better choices for Manitoba families,” said Dr. Paul Van Caeseele, medical director at Cadham County Laboratory. “SMA screening will diagnose babies before they have an irreversible disease and link them to early care that will give them many more opportunities to live an active, healthy life.” Trending Stories
National Defense considers possible “effects” after cyber attack on military contractor Why is China buzzing with Canadian and Australian planes? Here’s what you need to know
Muscular Dystrophy Canada will donate $ 235,000 to the lab over a two-year period to support the expansion. The story goes on under the ad 4:46 New technology that connects parents and newborns at the NICU of St. Boniface Hospital New technology that connects parents and newborns at the NICU of St. Boniface Hospital – December 23, 2021 “Early diagnosis is the key to improving outcomes for babies born with metabolic, endocrine or genetic disorders such as spinal muscular atrophy,” said Health Secretary Audrey Gordon. “Our government is proud to work with our partners across the healthcare system to extend the neonatal screening program to include SMA testing, because we know it is the first step in accessing treatment and ensuring the best results for families “. © 2022 Global News, part of Corus Entertainment Inc.
